Travere Therapeutics, Inc.TVTXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
4.53%
↑ 105% vs avg
Percentile
P91
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-98.06%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 4.53% | +104.0% |
| 2024 | -113.98% | +49.3% |
| 2023 | -224.63% | +17.9% |
| 2022 | -273.54% | -95.5% |
| 2021 | -139.91% | -91.2% |
| 2020 | -73.19% | -19.7% |
| 2019 | -61.15% | -36.8% |
| 2018 | -44.68% | -79.0% |
| 2017 | -24.96% | +14.0% |
| 2016 | -29.03% | - |